Findings

What do systematic reviews say?

50 questions · 52 findings · 15 reviews · Musculoskeletal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 14 · 26.9%GRADE not reported 3 · 5.8%Very low 11 · 21.2%Low 18 · 34.6%Moderate 5 · 9.6%High 1 · 1.9%

Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone

Quality of life (mental component) (short‐term) SF‐36 physical component scale from 0 to 100 (higher is better quality of life). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Acupuncture vs advice plus exercise

Pain (short‐term) · patients with hip osteoarthritis

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs advice plus exercise

Function (short‐term) · patients with hip osteoarthritis

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs sham

Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 105 participants
Moderate

Acupuncture as an addition to patient education vs education alone

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
GRADE not reported

Acupuncture as an addition to patient education vs education alone

Function (short‐term) DRI scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
GRADE not reported

Acupuncture as an addition to patient education vs education alone

Quality of life (short‐term) GSI scale from 0 to 10 (higher is worse quality of life). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
GRADE not reported

Acupuncture vs NSAIDs

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Acupuncture vs NSAIDs

Function (short‐term) Harris function score from: 0 to 47 (higher is better function). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Acupuncture as an addition to the routine primary care that trial participants were receiving from their physicians vs routine primary physician care alone

Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis

1 finding from 1 review

Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Celecoxib vs NSAIDs

Short‐term serious adverse events · patients with rheumatoid arthritis

Celecoxib showed no clear difference in short‐term serious adverse events compared with traditional NSAIDs (low certainty).

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
Peto OR 0.71 [0.39, 1.28]
5 studies · 2154 participants
Low

Celecoxib vs placebo

Short‐term serious adverse events · patients with rheumatoid arthritis

Celecoxib showed no clear difference in short‐term serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
Peto OR 0.87 [0.28, 2.69]
1 study · 706 participants
Low

Intervention not reported

Short term serious adverse effects from trials

The review found no eligible studies for this question.

1 finding from 1 review

Aquatic exercise for the treatment of knee and hip osteoarthritis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life Short Form‐12 · people following primary uncemented THA

1 finding from 1 review

Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve… 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 81 participants
Very low

Relaxation vs usual care

Pain as assessed post‐intervention Short Form ‐ McGill Pain Questionnaire Total Score. Scale from: 0 to 78 · patients with fibromyalgia

1 finding from 1 review

Mind and body therapy for fibromyalgia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Chondroitin vs placebo

Pain on a 0 to 100 mm scale ‐ Short‐term studies (< 6 months)—dose ≥ 800 mg/d · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1077 participants
Low

Chondroitin with or without glucosamine vs placebo or control

Pain (short‐ and long‐term) Scale from 0 to 100 (lower is better) · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
22 studies · 3038 participants
Low

Chondroitin with or without glucosamine vs placebo or control

Physical function · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1163 participants
Moderate

Chondroitin with or without glucosamine vs placebo or control

Composite Measure of Pain, Function and Disability as · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 2334 participants
Moderate